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ABSTRACT

BACKGROUND & AIMS: Non-alcoholic fatty liver disease is now the leading liver disease in North America. The progression of non-alcoholic fatty liver disease to the inflammatory condition, non-alcoholic steatohepatitis is complex and currently not well understood. Intestinal microbial dysbiosis has been implicated in the development of non-alcoholic fatty liver disease and progression of non-alcoholic steatohepatitis. Volatile organic compounds are byproducts of microbial metabolism in the gut that may enter portal circulation and have hepatotoxic effects contributing to the pathogenesis of non-alcoholic steatohepatitis. To test this hypothesis, we measured volatile organic compounds in cecal luminal contents and portal venous blood in a mouse model of non-alcoholic steatohepatitis. 

METHODS: Gas chromatography-mass spectrometry analysis was conducted on cecal content and portal vein blood for volatile organic compound detection from mice fed a methionine and choline deficient diet, which induces non-alcoholic steatohepatitis. The colonic microbiome was studied by 16S rRNA gene amplification using the Illumina MiSeq platform. 

RESULTS: Sixty-eight volatile organic compounds were detected in cecal luminal content, a subset of which was also present in portal venous blood. Importantly, differences in portal venous volatile organic compounds were associated with diet-induced steatohepatitis establishing a biochemical link between gut microbiota-derived volatile organic compounds and increased susceptibility to non-alcoholic steatohepatitis.

CONCLUSION: Our model creates a novel tool to further study the role of gut-derived volatile organic compounds in the pathogenesis of non-alcoholic steatohepatitis.



INTRODUCTION

	Non-alcoholic fatty liver disease (NAFLD) is commonly associated with obesity and has emerged as the leading cause of liver disease in North America  ADDIN EN.CITE 1. Although most individuals will have benign accumulation of intrahepatic fat, in certain cases inflammation occurs. The appearance of inflammation and fibrosis indicate a worsening of the disease, called non-alcoholic steatohepatitis (NASH) that may progress over years to liver cirrhosis and hepatocellular carcinoma  ADDIN EN.CITE  .
	The etiology of NAFLD is complex and remains poorly understood. To date a number of mechanisms have been implicated in the progression of NAFLD to NASH  ADDIN EN.CITE 4. Studies have shown that genetic factors may contribute to NASH. In addition, cellular stress such as the generation of reactive oxygen species and endoplasmic reticulum stress may contribute to the progression of NASH  ADDIN EN.CITE 5. The release of proinflammatory molecules from adipose tissue, activation of the immune system by microbial pattern recognition receptors including toll-like receptors (TLRs), and the NLRP3 inflammasome have all been implicated in the pathogenesis of NASH  ADDIN EN.CITE 6-8. 
	Dysbiosis of the gut microbiota has also been associated with NAFLD in humans and mice  ADDIN EN.CITE  . In obese humans with NAFLD, an over-representation of Lactobacillus species and under-representation of Oscillibacter has been observed  ADDIN EN.CITE 9. Microbial metabolism results in the production of hundreds of volatile organic compounds (VOCs), the effects of which are largely unknown. Recently, detection of fecal VOCs was shown to be able to differentiate obese patients with NAFLD from healthy individuals  ADDIN EN.CITE 9. It has been suggested that absorption of VOCs such as ethanol and other potentially toxic compounds from the intestine may have deleterious effects on the host liver. Essential to this theory is the presence of gut derived VOCs in the portal circulation, thus exposing the liver to these xenobiotic compounds  HYPERLINK \l "_ENREF_10" \o "Mochalski, 2013 #119"  ADDIN EN.CITE <EndNote><Cite><Author>Mochalski</Author><Year>2013</Year><RecNum>119</RecNum><DisplayText><style face="superscript">10</style></DisplayText><record><rec-number>119</rec-number><foreign-keys><key app="EN" db-id="edasfdf93d9f9oed99rxvtxtfaxav5tf05f5" timestamp="1423253618">119</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mochalski, P.</author><author>Sponring, A.</author><author>King, J.</author><author>Unterkofler, K.</author><author>Troppmair, J.</author><author>Amann, A.</author></authors></contributors><auth-address>Breath Research Institute, Austrian Academy of Sciences, Rathausplatz 4, A-6850 Dornbirn, Austria. Pawel.Mochalski@oeaw.ac.at.</auth-address><titles><title>Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells (HepG2) in vitro</title><secondary-title>Cancer Cell Int</secondary-title><alt-title>Cancer cell international</alt-title></titles><periodical><full-title>Cancer Cell Int</full-title><abbr-1>Cancer cell international</abbr-1></periodical><alt-periodical><full-title>Cancer Cell Int</full-title><abbr-1>Cancer cell international</abbr-1></alt-periodical><pages>72</pages><volume>13</volume><number>1</number><dates><year>2013</year></dates><isbn>1475-2867 (Electronic)&#xD;1475-2867 (Linking)</isbn><accession-num>23870484</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23870484</url></related-urls></urls><custom2>3717104</custom2><electronic-resource-num>10.1186/1475-2867-13-72</electronic-resource-num></record></Cite></EndNote>10. This study was designed to assess whether gut-derived volatile organic compounds enter the portal venous circulation and whether this could be a determinant of inflammation and liver injury in a murine model of NASH.












MATERIALS AND METHODS

Animals and Housing
The study protocol was approved by the University of Calgary Animal Care Committee and conformed to the Guidelines for the Care and Use of Laboratory Animals. Six-week old, male C57BL/6 mice were purchased from Jackson Laboratory (Bar Harbor, Maine USA) and kept on a 12-hour light-dark cycle in a temperature and humidity controlled room at the University of Calgary Foothills Campus. All animals had free access to drinking water. At eight weeks of age mice (n=6/group) were randomized to receive either a methionine and choline deficient (MCD) diet (4.2 kcal/g) or control chow diet (3.8 kcal/g) ad libitum for 21 days (MP Biomedicals Solon, OH, USA). Currently, MCD diet-induced NASH is one of the most commonly used mouse models to study the progression of NASH  ADDIN EN.CITE 11-13. Similar to patients with NASH, mice develop steatosis, inflammation and hepatocellular damage although they do not display an obese phenotype HYPERLINK \l "_ENREF_12" \o "Reid, 2015 #146"  ADDIN EN.CITE <EndNote><Cite><Author>Reid</Author><Year>2015</Year><RecNum>146</RecNum><DisplayText><style face="superscript">12</style></DisplayText><record><rec-number>146</rec-number><foreign-keys><key app="EN" db-id="edasfdf93d9f9oed99rxvtxtfaxav5tf05f5" timestamp="1448904442">146</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Reid, D. T.</author><author>Eksteen, B.</author></authors></contributors><auth-address>Snyder Institute for Chronic Diseases,Cumming School of Medicine,University of Calgary,Calgary,Alberta,Canada.</auth-address><titles><title>Murine models provide insight to the development of non-alcoholic fatty liver disease</title><secondary-title>Nutr Res Rev</secondary-title></titles><periodical><full-title>Nutr Res Rev</full-title></periodical><pages>1-10</pages><keywords><keyword>ALT alanine aminotransferase</keyword><keyword>HCC hepatocellular carcinoma</keyword><keyword>HFD high-fat diet</keyword><keyword>MCD methionine- and choline-deficient</keyword><keyword>NAFLD non-alcoholic fatty liver disease</keyword><keyword>NASH non-alcoholic steatohepatitis</keyword><keyword>TPN total parenteral nutrition</keyword><keyword>Animal models</keyword><keyword>Non-alcoholic fatty liver</keyword><keyword>Non-alcoholic steatohepatitis</keyword><keyword>Obesity</keyword></keywords><dates><year>2015</year><pub-dates><date>Oct 23</date></pub-dates></dates><isbn>1475-2700 (Electronic)&#xD;0954-4224 (Linking)</isbn><accession-num>26494024</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/26494024</url></related-urls></urls><electronic-resource-num>10.1017/S0954422415000128</electronic-resource-num></record></Cite></EndNote>12. Use of the MCD diet model allows the study of inflammatory pathways associated with the initiation and progression of NASH and remains the best mouse model to study NASH HYPERLINK \l "_ENREF_13" \o "Machado, 2015 #143"  ADDIN EN.CITE <EndNote><Cite><Author>Machado</Author><Year>2015</Year><RecNum>143</RecNum><DisplayText><style face="superscript">13</style></DisplayText><record><rec-number>143</rec-number><foreign-keys><key app="EN" db-id="edasfdf93d9f9oed99rxvtxtfaxav5tf05f5" timestamp="1435271013">143</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Machado, M. V.</author><author>Michelotti, G. A.</author><author>Xie, G.</author><author>de Almeida, T. P.</author><author>Boursier, J.</author><author>Bohnic, B.</author><author>Guy, C. D.</author><author>Diehl, A. M.</author></authors></contributors><auth-address>Division of Gastroenterology, Department of Medicine, Duke University Medical Center, Durham, NC 27710, United States of America; Gastroenterology Department, Hospital de Santa Maria, CHLN, Lisbon, Portugal.&#xD;Division of Gastroenterology, Department of Medicine, Duke University Medical Center, Durham, NC 27710, United States of America.&#xD;Division of Endocrinology, Duke University Medical Center, Durham, NC 27710, United States of America.&#xD;Division of Pathology, Duke University Medical Center, Durham, NC 27710, United States of America.</auth-address><titles><title>Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease</title><secondary-title>PLoS One</secondary-title></titles><periodical><full-title>PloS one</full-title><abbr-1>PLoS One</abbr-1></periodical><pages>e0127991</pages><volume>10</volume><number>5</number><dates><year>2015</year></dates><isbn>1932-6203 (Electronic)&#xD;1932-6203 (Linking)</isbn><accession-num>26017539</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/26017539</url></related-urls></urls><custom2>4446215</custom2><electronic-resource-num>10.1371/journal.pone.0127991</electronic-resource-num></record></Cite></EndNote>13. 

Sample collection
Animals were anesthetized (Isoflurane) and whole blood (approx. 500ul) was collected from the portal vein via venous puncture. For VOC analysis, serum was separated from whole blood and cecal content was removed and stored in individual 2mL Supelco glass vials with PTFE/silicon septa (Supelco Analytical, Bellefonte, PA, USA).  Remaining serum was frozen at -20°C for alanine aminotransferase (ALT) analysis (Calgary Laboratory Services). Cecal content was snap frozen and stored at -80°C.  Liver tissue was excised and rapidly fixed in 10% neutral-buffered formalin for histological assessment or placed in cold phosphate buffered saline for flow cytometry analysis.

NAFLD Activity Score (NAS) 
	 The NAS is a valid and reliable histological scoring tool that was developed for the purpose of numerically rating the progression of NAFLD in patient liver biopsies  ADDIN EN.CITE 14. The scoring includes measurement of steatosis grade (0-no steatosis, 1 - <50% steatosis, 2 - > 50% steatosis, 3 - >50% steatosis + microvesicular steatosis), hepatocyte ballooning (0- none, 1- <66%, 2- >66% hepatocyte involvement) and inflammation (0-no foci, 1- <2 foci, 2- 2-4 foci, 3- +4 foci). A score of 4 or above signifies the development of NASH 15. 

Leukocyte recruitment
	Flow cytometry was employed for the quantification of resident and recruited leukocytes in the liver. Briefly, fresh liver tissue was placed in cold phosphate buffered saline containing 0.5% fetal calf serum and 2mM EDTA and immediately homogenized using a gentleMACS tissue dissociator (Miltenyi Biotec Inc, Auburn CA, USA). Tissue homogenate was filtered through a 60 micron mesh to achieve a single cell suspension. Following centrifugation, cells were layered on a 33%/77%Percoll gradient and spun at room temperature at 600rcf for 20 minutes (GE Healthcare Bio-Sciences AB, Uppsala Sweden). Leukocytes were removed from the gradient, pelleted and resuspended in cold FACS buffer (PBS, 0.5% BSA and 2mM EDTA) followed by incubation with antibodies for flow cytometry at 4°C for 2 hours. The antibodies used include Ly-6C, Ly-6G, CD3, NK1.1 (BD Biosciences), F4/80 (eBioscience), CD4, CD8 (Abcam) and CCR2 (R&D Systems).  Data was collected on a FACS Aria II (BD Biosciences) using facs diva software and analyzed by Kaluza software (Beckman coulter). 

Gas Chromatography-Mass Spectrometry (GC-MS) VOC Processing
Samples of cecal luminal contents as well as portal vein serum were collected in 2ml headspace glass vials and frozen within 4 hours of collection. Samples of each experimental diet alone were also placed in individual 2ml headspace glass vials for analysis. All samples were shipped on dry ice to the University of Liverpool for chemical analysis, and immediately stored at -20oC. Prior to headspace analysis each sample was defrosted by immersing the vial in a water bath at 60oC for 30 seconds and thereafter the sample was baked at 60oC for 30 minutes prior to and during extraction of VOCs from the headspace with a solid-phase micro-extraction (SPME) fibre.
	The SPME fibre was 85 μm thick and consisted of carboxen/ polydimethylsiloxane (Sigma Aldrich, Dorset, UK). The fibre was exposed to the headspace above the stool or serum sample for 20 minutes and after extraction the VOCs were analysed by GC-MS (Perkin Elmer Clarus 500 quadrupole, Beaconsfield, UK). The VOCs were thermally desorbed from the fibre at 220oC in the injection port of the GC-MS for 5 minutes. Injection was made in splitless mode and a split of 50 ml/min was turned on two minutes into the run.
	Helium carrier gas of 99.996% purity (BOC, Sheffield, UK) was passed through a helium purification system, ExcelasorbTM (Supelco, Poole, UK) at 1 ml min-1. The GC column was a 60 metre long Zebron ZB-624 capillary column with an inner diameter of 0.25 mm and a film thickness of 1.4 μm (Phenomenex, Macclesfield, UK). Its composition consisted of 94% dimethyl polysiloxane and 6% cyanopropyl-phenyl.
	The initial GC oven temperature was held at 40oC for 1 minute and was then ramped up at a rate of 5oC/min to 220oC with a 4 minute hold at this temperature to give a total run time of 41 minutes. The mass spectrometer was run in the electron impact (EI) ionization mode, scanning ion mass fragments from 10 to 300 m/z with an inter-scan delay of 0.1 sec and a resolution of 1000 at FWHM (Full Width at Half Maximum). A 3 minute solvent delay was used at the start of the run. 

GC-MS VOC Analysis
The GC-MS data was processed using a pipeline involving the Automated Mass Spectral Deconvolution and Identification System software (AMDIS, Version 2.71, 2012), the NIST mass spectral library (version 2.0, 2011) and the R (Reference R core team) package Metab  HYPERLINK \l "_ENREF_16" \o "Aggio, 2011 #123"  ADDIN EN.CITE <EndNote><Cite><Author>Aggio</Author><Year>2011</Year><RecNum>123</RecNum><DisplayText><style face="superscript">16</style></DisplayText><record><rec-number>123</rec-number><foreign-keys><key app="EN" db-id="edasfdf93d9f9oed99rxvtxtfaxav5tf05f5" timestamp="1423607186">123</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Aggio, R.</author><author>Villas-Boas, S. G.</author><author>Ruggiero, K.</author></authors></contributors><auth-address>Centre for Microbial Innovation, School of Biological Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.</auth-address><titles><title>Metab: an R package for high-throughput analysis of metabolomics data generated by GC-MS</title><secondary-title>Bioinformatics</secondary-title><alt-title>Bioinformatics</alt-title></titles><periodical><full-title>Bioinformatics</full-title><abbr-1>Bioinformatics</abbr-1></periodical><alt-periodical><full-title>Bioinformatics</full-title><abbr-1>Bioinformatics</abbr-1></alt-periodical><pages>2316-8</pages><volume>27</volume><number>16</number><keywords><keyword>*Gas Chromatography-Mass Spectrometry</keyword><keyword>Humans</keyword><keyword>Metabolomics/*methods</keyword><keyword>*Software</keyword></keywords><dates><year>2011</year><pub-dates><date>Aug 15</date></pub-dates></dates><isbn>1367-4811 (Electronic)&#xD;1367-4803 (Linking)</isbn><accession-num>21697128</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21697128</url></related-urls></urls><electronic-resource-num>10.1093/bioinformatics/btr379</electronic-resource-num></record></Cite></EndNote>16. AMDIS and NIST were used to build a VOC library containing 283 metabolites present in the samples analyzed in this study. A forward and reverse match of 800/1000 and above was used for tentative peak identification. Peaks that could not be identified by the required match criteria were added to the library as ‘unknowns’ with their retention times recorded. Using this VOC library, the AMDIS report generation tool was applied for deconvoluting GC-MS chromatograms and identifying metabolites. The report generated by AMDIS was further processed by Metab in order to confirm the identity of metabolites and correct their relative abundances. Those compounds found to be present in less than 50% of samples from any one of the diet groups were removed from the data set; so for example, a compound present in only 2 out of the 6 chow diet fed mice would be removed and a compound present in 3 or more of the chow diet fed mice would be retained in the data set for further statistical analysis. 

DNA Extraction and 16S rRNA gene Amplification (Illumina MiSeq)
DNA extraction was performed using a custom protocol and sequence amplification of the 16S rRNA gene variable 3 (V3) region was conducted as previously described  ADDIN EN.CITE 17. Briefly, 300 uL of sample was resuspended in 800µL of 200 mM NaPO4, 100µL of guanidine thiocyanate-EDTA-Sarkosyl. The solution was homogenized using 0.2g of 0.1mm glass beads (Mo Bio, California, USA). Enzymatic lysis was performed using 50µL of lysozyme (100mg/mL), 50µL mutanolysin (10U/µL), 10µL RNase A (10mg/mL), and incubation at 37oC for 1 hour followed by the addition of 25µL 25% sodium dodecyl sulphate, 25µL proteinase K, and 62.5µL 5M NaCl followed by incubation at 65oC for 1 hour.  Samples were then pelleted via centrifugation at 12,000 x g and supernatant removed to a new microcentrifuge tube. An equal volume of phenol-chloroform-isoamyl alcohol was added and the sample centrifuged.  The solution with the lowest density was transferred to a new microcentrifuge tube to which 200µL of DNA binding buffer (Zymo, California, USA) was added. Solution was transferred to a DNA column (Zymo), washed, and DNA eluted using sterilized water.
Following this protocol, amplification of the 16S rRNA gene variable 3 (V3) was performed as previously described  ADDIN EN.CITE 17.  Briefly, 341F and 518R 16S rRNA primers were modified for adaptation to the Illumina platform and included the addition of 6-base pair, unique barcodes to the forward primer, allowing for multiplex amplification.  PCR amplification, separation by gel electrophoresis, and gel extraction were completed as described in  ADDIN EN.CITE 17 with some modifications.  Specifically, the amount of primer decreased to 5pmol each, a Taq, polymerase (Life Technologies) was used for amplification and the cycling times were changed to 30sec for each step. Products were then sequenced using the Illumina MiSeq platform.

Sequence Processing and Analysis
Bacterial Taxonomic Identification and Diversity Analysis
Custom Perl scripts were developed to process 16S rRNA gene sequences from Illumina sequencing. First, Cutadapt 18 was utilized to trim any reads surpassing the length of the V3 region. Resulting paired-end sequences were aligned with PANDAseq 19. Operational taxonomic units (OTUs) were picked using AbundantOTU+ 20 with a clustering threshold of 97%. Taxonomy was assigned using the Ribosomal Database Project classified 21 against the Greengenes reference database at the genus level  ADDIN EN.CITE 22. Samples were rarified to an equal number of sequences for analyses. α- and β- diversity measures were calculated using the phyloseq R package 23. Summaries of the relative abundances of taxonomies were computed using Quantitative Insights Into Microbial Ecology (QIIME)  ADDIN EN.CITE 24. Principle coordinates analysis was generated based on an unweighted UniFrac distance matrix  HYPERLINK \l "_ENREF_25" \o "Lozupone, 2005 #139"  ADDIN EN.CITE <EndNote><Cite><Author>Lozupone</Author><Year>2005</Year><RecNum>139</RecNum><DisplayText><style face="superscript">25</style></DisplayText><record><rec-number>139</rec-number><foreign-keys><key app="EN" db-id="edasfdf93d9f9oed99rxvtxtfaxav5tf05f5" timestamp="1426178261">139</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lozupone, C.</author><author>Knight, R.</author></authors></contributors><auth-address>Department of Chemistry and Biochemistry, University of Colorado, Boulder, CO 80309, USA.</auth-address><titles><title>UniFrac: a new phylogenetic method for comparing microbial communities</title><secondary-title>Appl Environ Microbiol</secondary-title><alt-title>Applied and environmental microbiology</alt-title></titles><periodical><full-title>Appl Environ Microbiol</full-title><abbr-1>Applied and environmental microbiology</abbr-1></periodical><alt-periodical><full-title>Appl Environ Microbiol</full-title><abbr-1>Applied and environmental microbiology</abbr-1></alt-periodical><pages>8228-35</pages><volume>71</volume><number>12</number><keywords><keyword>Bacteria/*classification/*genetics</keyword><keyword>*Genetic Techniques</keyword><keyword>Geography</keyword><keyword>*Phylogeny</keyword><keyword>RNA, Ribosomal, 16S/*genetics</keyword></keywords><dates><year>2005</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0099-2240 (Print)&#xD;0099-2240 (Linking)</isbn><accession-num>16332807</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/16332807</url></related-urls></urls><custom2>1317376</custom2><electronic-resource-num>10.1128/AEM.71.12.8228-8235.2005</electronic-resource-num></record></Cite></EndNote>25.

Inferred Metagenome
Metagenomic inference was conducted through QIIME and PICRUSt  ADDIN EN.CITE  . Aligned sequences from the PANDAseq output were used in a closed reference OTU picking step in QIIME. Sequences were binned to OTUs with a 97% similarity relative to the Greengenes reference set of 16S rDNA sequences  ADDIN EN.CITE 22. Sequences that did not match within the 97% similarity threshold were written to a failures file and discarded from further analysis. The 81,535 sequences of the 1,928,646 sequences compiled in the study did not match a reference OTU, resulting in a failure rate of 4.22%. The identified 16S sequences were normalized based on copy number to more accurately estimate abundances. The predicted metagenomic content was inferred from the normalized OTU table relative to KEGG orthologues  HYPERLINK \l "_ENREF_27" \o "Kanehisa, 2000 #116"  ADDIN EN.CITE <EndNote><Cite><Author>Kanehisa</Author><Year>2000</Year><RecNum>116</RecNum><DisplayText><style face="superscript">27</style></DisplayText><record><rec-number>116</rec-number><foreign-keys><key app="EN" db-id="edasfdf93d9f9oed99rxvtxtfaxav5tf05f5" timestamp="1422506571">116</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kanehisa, M.</author><author>Goto, S.</author></authors></contributors><auth-address>Institute for Chemical Research, Kyoto University, Uji, Kyoto 611-0011, Japan. kanehisa@kuicr.kyoto-u.ac.jp</auth-address><titles><title>KEGG: kyoto encyclopedia of genes and genomes</title><secondary-title>Nucleic Acids Res</secondary-title><alt-title>Nucleic acids research</alt-title></titles><periodical><full-title>Nucleic Acids Res</full-title><abbr-1>Nucleic acids research</abbr-1></periodical><alt-periodical><full-title>Nucleic Acids Res</full-title><abbr-1>Nucleic acids research</abbr-1></alt-periodical><pages>27-30</pages><volume>28</volume><number>1</number><keywords><keyword>Animals</keyword><keyword>*Databases, Factual</keyword><keyword>Gene Expression</keyword><keyword>*Genome</keyword><keyword>Humans</keyword><keyword>Information Storage and Retrieval</keyword><keyword>Japan</keyword><keyword>Proteins/genetics/metabolism</keyword></keywords><dates><year>2000</year><pub-dates><date>Jan 1</date></pub-dates></dates><isbn>0305-1048 (Print)&#xD;0305-1048 (Linking)</isbn><accession-num>10592173</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/10592173</url></related-urls></urls><custom2>102409</custom2></record></Cite></EndNote>27. These inferences were made in PICRUSt through a phylogenetic method using Wagner parsimony. Taxa without available full genomes were inferred through this method relative to their distance from those with fully sequenced genomes. The Nearest Sequenced Taxon Index (NSTI) was calculated for each sample to estimate confidence in the predictions (Supp. Table 1). These predicted KEGG orthologues were categorized according to their function at Level 3 and used in the subsequent correlation analysis.

Correlation Analysis
Abundance data of microbial composition, detected VOCs, and the inferred metagenome for each sample were combined for correlation analysis. Pearson correlations were calculated for the MCD group with the Galaxy portal from the Microbiome Analysis Centre  HYPERLINK \l "_ENREF_28" \o "Naqvi, 2010 #134"  ADDIN EN.CITE <EndNote><Cite><Author>Naqvi</Author><Year>2010</Year><RecNum>134</RecNum><DisplayText><style face="superscript">28</style></DisplayText><record><rec-number>134</rec-number><foreign-keys><key app="EN" db-id="edasfdf93d9f9oed99rxvtxtfaxav5tf05f5" timestamp="1425577606">134</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Naqvi, A.</author><author>Rangwala, H.</author><author>Keshavarzian, A.</author><author>Gillevet, P.</author></authors></contributors><auth-address>Microbiome Analysis Center, Manassas, VA 20110, USA.</auth-address><titles><title>Network-based modeling of the human gut microbiome</title><secondary-title>Chem Biodivers</secondary-title><alt-title>Chemistry &amp; biodiversity</alt-title></titles><periodical><full-title>Chem Biodivers</full-title><abbr-1>Chemistry &amp; biodiversity</abbr-1></periodical><alt-periodical><full-title>Chem Biodivers</full-title><abbr-1>Chemistry &amp; biodiversity</abbr-1></alt-periodical><pages>1040-50</pages><volume>7</volume><number>5</number><keywords><keyword>Colon/*microbiology</keyword><keyword>Humans</keyword><keyword>Metabolic Networks and Pathways</keyword><keyword>*Metagenome</keyword><keyword>*Models, Biological</keyword></keywords><dates><year>2010</year><pub-dates><date>May</date></pub-dates></dates><isbn>1612-1880 (Electronic)&#xD;1612-1872 (Linking)</isbn><accession-num>20491063</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/20491063</url></related-urls></urls><custom2>3681515</custom2><electronic-resource-num>10.1002/cbdv.200900324</electronic-resource-num></record></Cite></EndNote>28. Correlations between -0.60 and 0.60 or with a p > 0.05 were discarded from the analysis.

Network Construction
Visualization of the network was constructed with Cytoscape v. 3.0.1  ADDIN EN.CITE 29. Sub-networks were constructed based on the presence of VOCs of interest that were significantly different from the controls. These were constrained to nodes that represented first neighbours.

Isolation and culture of primary murine liver-resident macrophages
Eight week old, male C57BL/6 mice (n=10) were exsanguinated and livers were collected into cold phosphate buffered saline containing 0.5% fetal calf serum and 2mM EDTA and immediately homogenized using a gentleMACS tissue dissociator (Miltenyi Biotec Inc, Auburn CA, USA). Tissue homogenate was filtered through a 60 micron mesh to achieve a single cell suspension. Macrophages were isolated using OptiPrep density gradient (iodixanol) (Sigma-aldrich, Oakville, Ontarioa, Canada). Isolated cells were pelleted, counted via trypan blue exclusion and cellular morphology and seeded at 3.0 x 105/well in sterile 96-well U-bottom plates in a final volume of 150μl (BD Falcon, Franklin Lakes, NJ, USA). Cells were cultured overnight at 37°C in RPMI culture medium 1640 (Gibco by Life technologies, Paisley, UK) supplemented with 10% heat-inactivated FBS, 10mM sterile filtered HEPES, penicillin-streptomycin and 0.05mM sterile β-mercaptoethanol (Gibco by Life technologies, Burlington, ON Canada). To have a sufficient yield of cells for all conditions to be carried out in triplicate, cells from pairs of mice were pooled. Following overnight incubation, non-adherent cells were washed from the plate with serum-free medium. Remaining cells were incubated with serum-free media containing 2-3 pentanedione at 50mM or 100mM for six hours at 37°C as previous evidence in the literature suggested a potential role for initiating inflammation and contributing to fibrosis  ADDIN EN.CITE  . Supernatants were harvested and stored at -80°C for cell death and cytokine analysis.

Lactate dehydrogenase assay for cell toxicity
Cell lysis was quantified by the release of lactate dehydrogenase (LDH) from harvested cell culture supernatant according to the manufacturer’s protocol (Promega, Madison, WI, USA). Maximum cell death was determined by lysing cells with lysis buffer provided by the manufacturer. The degree of cellular toxicity was calculated by first subtracting the observed background optical density (O.D.) from all the wells then dividing the O.D. of the experimental well by the O.D. of the maximum cell death then multiplying by 100 as given in the following equation: % Cytoxicity = Experimental LDH release (O.D.490)/Maximum LDH release (O.D.490) X 100.	

Multiplex cytokine analysis
Cell culture supernatants were analyzed for chemokine and cytokine release using a commercial mouse cytokine 31-plex Discovery Assay by Eve Tech (Eve Technologies, Calgary, AB, Canada). The analytes include: eotaxin, G-CSF, GM-CSF, INF-γ, IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-9, IL-10, IL-12(p40), IL-12(p70), IL-13, IL-15, IL-17, IP-10, KC, LIF, MCP-1, MIG, MIP-1α, MIP-1β, MIP-2, RANTES, TNF-α and VEG-F. Briefly, 31 analytes were simultaneously tested in a single well using multiplexing LASER Bead Technology and colour-coded polystyrene beads. Using dual-laser technology and flow cytometry the analyte can be identified based on the bead colour whereas the concentration of analyte present is quantified by the fluorescent intensity using a standard curve. Values were normalized to percent of living cells and are presented as relative secretion in pg/ml. 



Statistical analyses
All data are expressed as mean ± SEM. Statistical analysis of data was carried out using student’s T test as indicated using GraphPad Prism v.6 and STatistical Analysis of Metagenomic Profiles (STAMP) ADDIN EN.CITE 32. Differences were considered statistically significant at P<0.05.  


RESULTS
MCD diet causes non-alcoholic steatohepatitis in mice
Feeding mice a diet deficient in methionine and choline is one of the most common models to study NASH HYPERLINK \l "_ENREF_12" \o "Reid, 2015 #146"  ADDIN EN.CITE <EndNote><Cite><Author>Reid</Author><Year>2015</Year><RecNum>146</RecNum><DisplayText><style face="superscript">12</style></DisplayText><record><rec-number>146</rec-number><foreign-keys><key app="EN" db-id="edasfdf93d9f9oed99rxvtxtfaxav5tf05f5" timestamp="1448904442">146</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Reid, D. T.</author><author>Eksteen, B.</author></authors></contributors><auth-address>Snyder Institute for Chronic Diseases,Cumming School of Medicine,University of Calgary,Calgary,Alberta,Canada.</auth-address><titles><title>Murine models provide insight to the development of non-alcoholic fatty liver disease</title><secondary-title>Nutr Res Rev</secondary-title></titles><periodical><full-title>Nutr Res Rev</full-title></periodical><pages>1-10</pages><keywords><keyword>ALT alanine aminotransferase</keyword><keyword>HCC hepatocellular carcinoma</keyword><keyword>HFD high-fat diet</keyword><keyword>MCD methionine- and choline-deficient</keyword><keyword>NAFLD non-alcoholic fatty liver disease</keyword><keyword>NASH non-alcoholic steatohepatitis</keyword><keyword>TPN total parenteral nutrition</keyword><keyword>Animal models</keyword><keyword>Non-alcoholic fatty liver</keyword><keyword>Non-alcoholic steatohepatitis</keyword><keyword>Obesity</keyword></keywords><dates><year>2015</year><pub-dates><date>Oct 23</date></pub-dates></dates><isbn>1475-2700 (Electronic)&#xD;0954-4224 (Linking)</isbn><accession-num>26494024</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/26494024</url></related-urls></urls><electronic-resource-num>10.1017/S0954422415000128</electronic-resource-num></record></Cite></EndNote>12. However, the exact mechanisms of inflammation and liver injury in this model remain unknown HYPERLINK \l "_ENREF_12" \o "Reid, 2015 #146"  ADDIN EN.CITE <EndNote><Cite><Author>Reid</Author><Year>2015</Year><RecNum>146</RecNum><DisplayText><style face="superscript">12</style></DisplayText><record><rec-number>146</rec-number><foreign-keys><key app="EN" db-id="edasfdf93d9f9oed99rxvtxtfaxav5tf05f5" timestamp="1448904442">146</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Reid, D. T.</author><author>Eksteen, B.</author></authors></contributors><auth-address>Snyder Institute for Chronic Diseases,Cumming School of Medicine,University of Calgary,Calgary,Alberta,Canada.</auth-address><titles><title>Murine models provide insight to the development of non-alcoholic fatty liver disease</title><secondary-title>Nutr Res Rev</secondary-title></titles><periodical><full-title>Nutr Res Rev</full-title></periodical><pages>1-10</pages><keywords><keyword>ALT alanine aminotransferase</keyword><keyword>HCC hepatocellular carcinoma</keyword><keyword>HFD high-fat diet</keyword><keyword>MCD methionine- and choline-deficient</keyword><keyword>NAFLD non-alcoholic fatty liver disease</keyword><keyword>NASH non-alcoholic steatohepatitis</keyword><keyword>TPN total parenteral nutrition</keyword><keyword>Animal models</keyword><keyword>Non-alcoholic fatty liver</keyword><keyword>Non-alcoholic steatohepatitis</keyword><keyword>Obesity</keyword></keywords><dates><year>2015</year><pub-dates><date>Oct 23</date></pub-dates></dates><isbn>1475-2700 (Electronic)&#xD;0954-4224 (Linking)</isbn><accession-num>26494024</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/26494024</url></related-urls></urls><electronic-resource-num>10.1017/S0954422415000128</electronic-resource-num></record></Cite></EndNote>12. Therefore, we evaluated gut VOC profiles in the MCD mice compared with standard chow-fed controls.
	MCD diet treatment resulted in liver injury as measured by elevated serum alanine aminotransferase levels compared to control mice (Figure 1A; p=0.01). Mice fed MCD diet developed liver steatosis, ballooning hepatocytes and inflammation resulting in a significantly higher NAS score compared to chow fed mice (Figure 1B; p=0.001). Histological assessment of liver tissue from mice fed MCD diet revealed the development of liver steatosis, hepatocellular injury and the recruitment of inflammatory cells compared to mice fed standard chow (Figure 1C-D). 









Figure 1. A. Serum ALT levels were significantly increased in mice fed MCD diet compared to chow diet as control (n=6/group). B. The NAS score was significantly higher for mice fed MCD diet compared to standard chow. C-D. Hematoxylin and eosin stain of representative liver sections in chow (C) and MCD diet (D) fed mice. Compared to chow fed mice, MCD diet feeding resulted in lipid accumulation (white arrow) and evidence of immune cell infiltration (black arrow). 20X magnification. PT; portal tract, CV; central vein.


MCD diet feeding results in a robust inflammatory response
	To further characterize the inflammation associated with MCD diet-induced NASH flow cytometry analysis was carried out on fresh liver tissue. Liver-resident macrophages, Kupffer cells made up the largest population of immune cells detected in the liver of chow fed mice (84.5% F4/80+ CCR2-) whereas there were very few recruited macrophages (0.2% F4/80+ CCR2+) (Figure 2A). In contrast, following 21 days of MCD diet feeding there was a decrease in Kupffer cells (6.8% F4/80+ CCR2-) and an increase in recruited macrophages (87.6% F4/80+ CCR2+) (Figure 2B). Recruited macrophages were significantly increased in the livers of mice fed MCD diet compared to standard chow mice (p=0.02) and Kupffer cells were significantly decreased following MCD diet treatment compared to chow fed mice (p<0.00001) (Figure 2C). In addition there was a significant increase in the total number of neutrophils (p=0.001), CD4+ T cells and NK cells (p<0.0003), CD8+ T cells (p<0.0002) and NKT cells (p<0.000001) following MCD diet feeding compared to chow diet (Figure 2C).
















 Figure 2. A. Liver-resident macrophages, Kupffer cells are abundant in chow fed mice (n=6). B. Feeding MCD diet results in a loss of Kupffer cells and a robust recruitment of CCR2+ monocyte-derived macrophages (n=6). C. Kupffer cells are significantly reduced (δ p<0.00001) while recruited monocytes are significantly increased (*p=0.02) along with neutrophils (**p=0.001), CD4+ T cells and NK cells (***p<0.0003), CD8+ T cells (****p<0.0002) and NKT cells (ζ p<0.000001) following MCD diet feeding compared to chow diet.






Volatile organic compounds are present in both portal blood and cecal luminal content 
Detection of specific VOCs from adults and children with NAFLD has been evaluated as a possible technique for the diagnosis of fatty liver disease  ADDIN EN.CITE   . However, the significance of circulating VOCs on liver pathology has only been studied in limited cases and the consequence of VOCs in the liver in vivo has not been evaluated  ADDIN EN.CITE  . For the first time we have documented that VOCs can be detected in both serum from the portal vein and cecal luminal content in this murine model of NASH. 
	In total 44 VOCs were detected in the portal vein serum and 68 VOCs were identified from the cecal luminal content. After removing VOCs originating from the diets (supp table 2), 20 VOCs from the portal vein blood and 32 VOCs from the cecal content were used in the final analysis. Ethanol and cyclopentane were ubiquitously detected in both the portal vein serum and cecal content in mice fed the MCD diet and chow diet (Table 1). 








TABLE 1. Frequency of occurrence of VOCs (%*) detected in the portal vein (PV) and cecal content (CC) of mice fed MCD diet or chow diet.
VOC	MCD Diet	Chow Diet
	PV	CC	PV	CC
ethanol	100	67	83	83
cyclopentane	83	83	100	50
2,3-pentanedione	100	100	---	---
2,3-butanedione	83	100	---	---
unknown alkane 33.41	83	67	---	---
1-hexanol	83	50	---	---
2-butanone	50	83	---	---
2,3 – octanedione	---	---	67	50
acetophenone	---	---	50	83
butanoic acid, ethyl ester	---	---	100	50
xylene	---	---	100	50
1-octen-3-ol	100	---	100	---
2-ethyl-1-hexanol	100	---	100	---
6-methyl-3-heptanone	83	---	83	---
2,8-dimethyl-undecane	67	---	100	---
2-methyl-butane	67	---	50	---
3-methyl-butanol	67	---	50	---
2-butenal	50	---	50	---
nitromethane	50	---	50	---
styrene	50	---	50	---
indole	---	100	---	100
phenol	---	100	---	100
3-methylbutanoic acid	---	83	---	100
4-methylphenol	---	83	---	67
acetaldehyde	---	83	---	83
1-propanol	---	67	---	50
*Percent frequency is calculated by dividing the number of animals positive for the VOC by the total number of animals sampled multiplied by 100 (n=6). 


Distinctive VOCs were identified in MCD diet fed mice 
Analysis of VOCs in samples from mice fed standard chow and MCD diet showed that identical compounds could be detected in both the portal vein serum and cecal content (Table 1). Importantly, 2,3 pentanedione and 2,3 butanedione were detected in over 80% of both the portal vein serum and cecal content in mice with steatohepatitis. Of the total VOCs detected in the portal vein of mice fed MCD diet, 9 occurred in over 80% of the samples. In mice fed standard chow, 8 VOCs occurred in over 80% of the portal vein samples. Out of the total VOCs detected in the cecal luminal content 9 occurred in over 80% of the samples in mice fed MCD diet whereas 6 VOCs occurred in over 80% of the samples from mice fed chow. 


Mice with steatohepatitis have reduced abundance of VOCs in portal vein serum and cecal luminal content
The only VOC detected in the portal vein of mice fed MCD diet that showed a significant reduction in abundance compared to chow fed mice was 6-methyl-3-heptanone (log abundance 12.8 vs 14.0 MCD diet vs chow respectively; p=0.002). In the cecal content, MCD diet fed mice had significantly reduced abundance of the volatile fatty acid 3-methy-butanoic compared to chow fed mice (log abundance 16.5 vs 18.0 MCD diet vs chow, respectively; p=0.0008). MCD diet feeding did not significantly increase the abundance of any VOCs in the portal vein or cecal luminal contents compared to chow fed mice.

MCD diet feeding resulted in changes in the gut microbiome in mice
VOCs present in the intestinal lumen originate predominately from the fermentation and metabolism of ingested food by the gut microbiota  HYPERLINK \l "_ENREF_36" \o "Probert, 2014 #120"  ADDIN EN.CITE <EndNote><Cite><Author>Probert</Author><Year>2014</Year><RecNum>120</RecNum><DisplayText><style face="superscript">36</style></DisplayText><record><rec-number>120</rec-number><foreign-keys><key app="EN" db-id="edasfdf93d9f9oed99rxvtxtfaxav5tf05f5" timestamp="1423498868">120</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Probert, C. S.</author><author>Reade, S.</author><author>Ahmed, I.</author></authors></contributors><auth-address>Department of Gastroenterology, Institute of Translational Medicine, University of Liverpool, Liverpool, L69 3BX, UK.</auth-address><titles><title>Fecal volatile organic compounds: a novel, cheaper method of diagnosing inflammatory bowel disease?</title><secondary-title>Expert Rev Clin Immunol</secondary-title><alt-title>Expert review of clinical immunology</alt-title></titles><periodical><full-title>Expert Rev Clin Immunol</full-title><abbr-1>Expert review of clinical immunology</abbr-1></periodical><alt-periodical><full-title>Expert Rev Clin Immunol</full-title><abbr-1>Expert review of clinical immunology</abbr-1></alt-periodical><pages>1129-31</pages><volume>10</volume><number>9</number><dates><year>2014</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1744-8409 (Electronic)&#xD;1744-666X (Linking)</isbn><accession-num>25066268</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/25066268</url></related-urls></urls><electronic-resource-num>10.1586/1744666X.2014.943664</electronic-resource-num></record></Cite></EndNote>36. To identify a link between VOCs and the microbiota in the cecal luminal contents, we conducted next-generation sequencing of the cecal content that revealed changes in the taxa at multiple levels following MCD diet feeding. To the best of our knowledge this is the first report of the microbial profiling of the microbiome of mice fed MCD diet compared to standard chow diet. PCoA was conducted to visualize the β-diversity in the microbiome between MCD diet and chow fed mice (Supp. Figure 1). 
	Mice with steatohepatitis demonstrated a similar dysbiosis to other murine models of NAFLD, obesity and metabolic syndrome including a reduction in Bifidobacterium (p=0.036) and Lactobacillus (p=0.009) and a significant increase in Enterococcus (p=0.029)  ADDIN EN.CITE 37-39 (Table 2). MCD diet feeding resulted in a phylum shift where Firmicutes became dominant over Bacteroidetes compared to standard chow. Specifically, four families from Firmicutes were increased after MCD diet including statistically significant increases in Aerococcaceae and Enterococcaceae. Ruminococcaceae Clostridium and Moraxellaceae Acinetobacter were also significantly elevated compared to chow-fed mice.  A reduction in Lachnospiraceae (p=0.001) and Blautia (p=0.003) abundance was observed following MCD diet feeding which is similar to changes seen in patients with advanced cirrhosis  ADDIN EN.CITE 40. 












TABLE 2. MCD diet feeding resulted in changes in the gut microbiota (phylum_class_order_family_genus)

Decreased in MCD diet	Relative Abundance	P value
	MCD	Chow	Difference	
Firmicutes_Clostridia_Clostridiales_Lachnospiraceae_Lachnospira	0	0.93	-0.93	0.0012
Firmicutes_Clostridia_Clostridiales_Lachnospiraceae_Blautia	0	0.23	-0.23	0.0026
Firmicutes_Bacilli_Lactobacillales_Lactobacilliaceae_Lactobacillus	0.03	2.93	-2.90	0.0092
Actinobacteria_Actinobacteria_Bifidobacteriales_Bifidobacteriaceae_
Bifidobacterium	0	0.07	-0.07	0.036
Verrucomicrobia_Verrucomicrobiae_Verrucomicrobiales_Verrucomicrobiaceae_Akkermansia	0	0.77	-0.77	0.039
Firmicutes_Bacilli_Lactobacillales_Lactobacilliaceae	0.03	2.97	-2.94	0.0095
Firmicutes_Clostridia_Clostridiales_Catabacteriaceae	0.23	1.77	-1.54	0.017

Increased in MCD diet				
Firmicutes_Bacilli_Lactobacillales_Aerococcaceae_Aerococcus	4.87	0	4.87	0.0022
Proteobacteria_Gammaproteobacteria_Pseudomonadales_Moraxellaceae_Acinetobacter	0.17	0	0.17	0.0064
Firmicutes_Clostridia_Clostridiales_Ruminococcaceae_Clostridium	0.10	0.07	0.03	0.019
Firmicutes_Bacilli_Lactobacillales_Enterococcaceae_Enterococcus	0.17	0	0.17	0.029





Inferred metagenome links VOCs, microbiome and NASH pathogenesis in MCD diet fed mice
Using the data generated from the microbiome sequencing we were able to conduct further analysis assessing the predicted functional potential of the identified microbes. Using the Kyoto Encyclopedia of Genes and Genomes (KEGG) we were able to construct an “inferred metagenome” by compiling the abundances of KEGG orthologues at level 3. Integrating the data from the detection of VOCs, microbiome and inferred metagenome we measured the correlations among these three factors. This exploratory analysis was restricted to the correlation of changes in the microbiome or the inferred metagenome relative to each specific VOC. We chose to look specifically at 2,3 pentanedione and 2,3 butanedione because previously published literature suggests a possible pro-inflammatory and pro-fibrotic role for these VOCs in alcoholic liver disease and lung fibrosis  ADDIN EN.CITE 41-43. Detection of 2,3 pentanedione was positively correlated with the presence of Bacteroides (r2=0.89; p=0.018), Alistipes (r2=0.85; p=0.033), Chryseobacteria (r2=0.87; p=0.024), Bifidobacterium (r2=0.81; p=0.042), Lachnospiraceae (r2=0.87; p=0.025), Novosphingobium (r2=-0.97; p=0.001) and negatively correlated to Lactobacillus (r2=-0.97; p=0.001)  (Figure 3). We also identified negative correlations between 2,3 pentanedione and microbial genes influencing the metabolism of drugs and xenobiotics by cytochrome P450 as well as retinol metabolism (r2= -0.90; p=0.01)  (Figure 3). There was also a significant correlation between 2,3 pentanedione and proximal tubule bicarbonate reclamation (r= 0.83; p=0.04) and xylene (r= -0.84; p=0.04). 2,3 butanedione was positively correlated with the presence of Lachnospiraceae, Ruminococcus, Escherichia and Bifidobacterium species from the cecal luminal content (Supp. Figure 2).  


Figure 3. A. Network analysis reveals correlations between 2,3 pentanedione, microbiome genes and inferred metagenome in mice fed MCD diet.







VOCs are cytotoxic and lead to the release of proinflammatory mediators in murine Kupffer cells

To further examine if VOCs alter liver biology, primary Kupffer cells from mice were isolated and cultured with 2,3 pentanedione. We observed a significant dose-dependent increase in cell death measured by lactate dehydrogenase release when Kupffer cells where incubated with 50mM 2,3 pentanedione (p<0.0001) or 100mM 2,3 pentanedione (p<0.001) compared to media alone (Figure 4A). There was also a significant increase in cell death between 50mM and 100mM 2,3 pentanedione (Figure 4A, p<0.0001). Treatment of Kupffer cells with 2,3 pentanedione resulted in the significant increase in the release of IL-1β (p<0.02), IL-2 (p<0.03), IL-3 (p<0.0001), IL-12(p40) (p<0.05), TNF-α (p<0.05) and MCP-1 (p<0.05) (Figure 4B). 











Figure 4. A. Treatment of Kupffer cells with 2,3 pentanedione results in dose-dependent increase in cell death. B. Treatment of Kupffer cells with 2,3 pentanedione leads to proinflammatory cytokine release. 






DISCUSSION

Previous evidence has demonstrated that fecal VOC profiles can be used to distinguish patients with NAFLD from healthy controls  ADDIN EN.CITE 9. However, establishing a direct link between gut-derived VOCs and presence in portal venous blood of patients with NAFLD is currently beyond any safe sampling procedures available. Therefore the present study was designed using a murine model of NASH. For the first time we have demonstrated that VOCs derived from the luminal cecal contents can be detected in the portal vein in mice and that they may be potent inflammatory mediators. Analyzing VOCs from the portal vein in a mouse model of NASH represents a novel tool for identifying the role of VOCs in liver pathology and may provide new insights for the design of targeted treatment strategies for NASH.
	 Metabolic stress is often associated with NAFLD and may be a key determinant for the progression of NASH. Both 2,3 butanedione and 2,3 pentanedione were uniquely detected in the portal vein of mice fed MCD diet, and likely originated in the colonic lumen. These VOCs have been found to be potent inhibitors of ι-threonine dehydrogenase (TDH) which is a mitochondrial enzyme responsible for the catabolism of ι-threonine to acetyl-CoA in the mammalian liver  ADDIN EN.CITE 44. In rats, decreased levels of TDH were correlated with worsened liver injury in CCl4-induced liver disease  ADDIN EN.CITE 30. It is possible that these VOCs may disrupt mitochondrial function within the liver adding to increased hepatic injury. In addition, the presence of 2,3 pentanedione was negatively associated with the genes influencing metabolism of drugs including xenobiotics by cytochrome P450 and could further indicate compromised metabolic function within the liver.
	Clinically, one of the most concerning aspects of NASH is its’ progression to liver fibrosis, cirrhosis and hepatocellular carcinoma 45. Previous studies have shown that inhaled 2,3 butanedione can lead to an irreversible fibrotic lung disease known as Bronchiolitis Obliterans (BO) and as such is no longer used in the food production industry as artificial butter seasoning  ADDIN EN.CITE 43.  Results of rats exposed to 2,3 pentanedione vapours also demonstrated increased fibrotic airway lesions  ADDIN EN.CITE 42. Further studies should evaluate the potential for these VOCs, detected here in portal vein serum, to lead to liver fibrosis. Acetaldehyde in the liver has been linked to the activation of hepatic stellate cells that result in liver fibrosis and interestingly the metabolism of acetaldehyde can lead to the production of 2,3 butanedione ADDIN EN.CITE  . It will be key to evaluate metabolites such as 2,3 butanedione and 2,3 pentanedione to help clarify the molecular mechanisms responsible for the activation of hepatic stellate cells and acetaldehyde-induced collagen synthesis 41. 
	Following identification of 2,3 butanedione and 2,3 pentanedione in both the luminal content and portal circulation of mice with NASH we wanted to evaluate how the presence of VOCs may contribute to hepatocellular injury and apoptosis and may modify the immune response within the liver microenvironment. Experiments reveal that VOCs are toxic to liver-resident macrophages and induce the release of proinflammatory cytokines. This suggests a role for VOCs to affect changes in the liver during obesity and steatohepatitis.
	Currently, there is a lack of a single mouse model of steatohepatitis that fully represents the development of steatohepatitis in human patients  ADDIN EN.CITE  . This results in the use of many different animal models to reflect certain aspects of NASH HYPERLINK \l "_ENREF_13" \o "Machado, 2015 #143"  ADDIN EN.CITE <EndNote><Cite><Author>Machado</Author><Year>2015</Year><RecNum>143</RecNum><DisplayText><style face="superscript">13</style></DisplayText><record><rec-number>143</rec-number><foreign-keys><key app="EN" db-id="edasfdf93d9f9oed99rxvtxtfaxav5tf05f5" timestamp="1435271013">143</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Machado, M. V.</author><author>Michelotti, G. A.</author><author>Xie, G.</author><author>de Almeida, T. P.</author><author>Boursier, J.</author><author>Bohnic, B.</author><author>Guy, C. D.</author><author>Diehl, A. M.</author></authors></contributors><auth-address>Division of Gastroenterology, Department of Medicine, Duke University Medical Center, Durham, NC 27710, United States of America; Gastroenterology Department, Hospital de Santa Maria, CHLN, Lisbon, Portugal.&#xD;Division of Gastroenterology, Department of Medicine, Duke University Medical Center, Durham, NC 27710, United States of America.&#xD;Division of Endocrinology, Duke University Medical Center, Durham, NC 27710, United States of America.&#xD;Division of Pathology, Duke University Medical Center, Durham, NC 27710, United States of America.</auth-address><titles><title>Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease</title><secondary-title>PLoS One</secondary-title></titles><periodical><full-title>PloS one</full-title><abbr-1>PLoS One</abbr-1></periodical><pages>e0127991</pages><volume>10</volume><number>5</number><dates><year>2015</year></dates><isbn>1932-6203 (Electronic)&#xD;1932-6203 (Linking)</isbn><accession-num>26017539</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/26017539</url></related-urls></urls><custom2>4446215</custom2><electronic-resource-num>10.1371/journal.pone.0127991</electronic-resource-num></record></Cite></EndNote>13. In this current study we employed the MCD diet to induce steatohepatitis that is a widely used experimental model of NASH. Future studies using a “westernized” type diet may provide further evidence of the interaction between diet, the gut microbiome and the production of VOCs that are critical in the development of NASH. It is interesting to note that fecal VOCs can be used to identify patients with NAFLD compared to healthy controls without controlling for the effect of diet ADDIN EN.CITE 9. This suggests that regardless of diet, the production of certain VOCs may contribute to the pathogenesis of NASH. 
	One of the observations made during this study was the frequency of short chain fatty acid (SCFA) VOCs detected in the mouse diets that were also detected in the cecal content of the mice. Since we were not able to determine the exact source of these specific SCFA in the cecal luminal contents they were removed from the current analysis. Future experiments will need to establish a method to identify VOCs originating from the mouse diets and those produced through metabolism of macronutrients and fermentation by host gut microbiota. Using a murine model to study the effect of VOCs is beneficial as we may be able to further understand the relationship between diet, microbial fermentation and VOC production.  
	In summary we have shown for the first time that it is feasible to sample portal vein blood and cecal luminal contents from mice for VOC analysis. This provides a new avenue for studying the effect of metabolites on the function of the liver during disease development. Continued evaluation of the role of specific VOCs in the liver will provide greater understanding the crosstalk between the gut and liver is critical to determining the pathogenesis of NAFLD.
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